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AbstrAct
Objectives To assess the cost-effectiveness of preferred 
intensity exercise programme for young people with 
depression compared with a treatment as usual control 
group.
Design A ‘within trial’ cost-effectiveness and cost-utility 
analysis conducted alongside a randomised controlled 
trial. The perspective of the analysis was the UK National 
Health Service and social services.
setting The intervention was provided in a community 
leisure centre setting.
Participants 86 young people aged 14–17 years 
attending Tier 2 and Tier 3 CAMHS (Child and Adolescent 
Mental Health Services) outpatient services presenting 
with depression.
Interventions The intervention comprised 12 separate 
sessions of circuit training over a 6-week period. Sessions 
were supervised by a qualified exercise therapist. 
Participants also received treatment as usual. The 
comparator group received treatment as usual.
results We found improvements in the Children’s 
Depression Inventory-2 (CDI-2) and estimated cost-
effectiveness at £61 per point improvement in CDI-2 for 
the exercise group compared with control. We found no 
evidence that the exercise intervention led to differences 
in quality-adjusted life years (QALY). QALYs were estimated 
using the EQ-5D-5L (5-level version of EuroQol-5 
dimension).
conclusions There is evidence that exercise can be an 
effective intervention for adolescents with depression and 
the current study shows that preferred intensity exercise 
could also represent a cost-effective intervention in terms 
of the CDI-2.
trial registration number NCT01474837.
bAckgrOunD
Depression is highly prevalent in adolescence1 
with the numbers of reported cases doubling 
between the mid-1980s and 2000s.2 Among 
community samples of adolescents, the prev-
alence of major depressive disorder (MDD) 
is reported to be between 4% and 8%.3 Addi-
tionally, it is estimated that 12% of children 
and adolescents may have subthreshold symp-
toms of depression.4 There is some evidence 
to suggest that exercise may have beneficial 
effects on depression in young people.5–8 A 
recent feasibility randomised controlled trial 
compared a moderate to strenuous exercise 
intervention to stretching for adolescents 
diagnosed with MDD.9 Statistically significant 
reductions in depression scores were observed 
for both groups. However, the study was limited 
by a small sample size (30 participants initially 
with 15 completing 12-month follow-up). For 
this reason, a randomised controlled trial was 
designed and conducted to determine the 
effectiveness of a preferred intensity exercise 
intervention on the depressive symptoms of 
adolescents with depression.10 11
With growing concern as to the affordability 
of healthcare, particularly in the context of 
the National Health Service (NHS) budget, it 
is important to consider the value for money 
afforded by any intervention in terms of both its 
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Research
strengths and limitations of this study
 ► Economic analysis conducted alongside a 
randomised trial of an exercise intervention for 
adolescents with depression.
 ► This study uses costs and effectiveness data 
collected directly from the trial population to 
estimate the cost-effectiveness of an exercise 
intervention for adolescents with depression.
 ► Appropriate statistical methods were adopted to 
control for baseline characteristics and missing 
data.
 ► The small sample size at follow-up limits the 
strength of the conclusions made.
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costs and effectiveness. Furthermore, the costs of child and 
adolescent mental health can be substantial with a recent 
study estimating total annual costs of emotional disorders in 
the UK at £1165 per person in 2007/2008 prices.12 Individ-
uals treated for depression during childhood can continue 
to incur substantial costs into adulthood.13 These consid-
erations should be contemplated when making resource 
allocation decisions.
However, there has been limited and inconclusive 
evidence looking at the health economic case for interven-
tions for child or adolescent depression. One study we are 
aware of looked at an exercise-related intervention.14 This 
was a cost-utility study of a dance intervention for adoles-
cent girls with internalising problems. The dance interven-
tion was considered cost-effective as it cost US$3830 per 
quality-adjusted life year (QALY). There have also been 
studies that conducted economic evaluations of adolescents 
with depression using non-exercise-based interventions. An 
economic evaluation was conducted in the USA alongside a 
randomised controlled trial for subjects with a major diag-
nosis of depression.15 16 Groups received either placebo, 
fluoxetine, cognitive–behavioural therapy (CBT) or a 
combination of fluoxetine and CBT. Researchers found that 
combination therapy with fluoxetine and CBT was highly 
likely to be cost-effective at 36 weeks. A study of the cost-effec-
tiveness of a collaborative care intervention was conducted 
on adolescents in the USA.17 This found the intervention to 
be cost-effective, at $18 239 per QALY gained. There have 
also been three UK studies looking at CBT in adolescents 
with depression. Byford and colleagues evaluated CBT in 
addition to selective serotonin reuptake inhibitors (SSRI) 
with normal clinical care.18 The comparator was SSRI plus 
normal clinical care alone. This study found only a 30% 
probability that CBT and SSRI would be more cost-effective 
than SSRI alone. Anderson and colleagues evaluated class-
room-based CBT compared with usual school provision of 
Personal, Social and Health Education.19 20 They found no 
evidence that the intervention was cost-effective. Comput-
erised CBT was also compared with a website control in a 
feasibility study.21 The authors concluded a future large-
scale study was feasible but the study was not powered to 
show differences in effects.
In order to add to this literature and to aid in deci-
sion-making, we conducted an economic evaluation 
alongside the aforementioned clinical trial.11 The aim of 
this economic evaluation was to examine the cost-effec-
tiveness of a preferred exercise intervention in addition 
to treatment as usual compared with treatment as usual 
alone. This article describes the methods used to conduct 
this economic analysis. We present the results in terms of 
both costs and effects for the brief exercise intervention 
compared with treatment as usual.
MethODs
randomised controlled trial
The current economic evaluation was conducted as an 
integral part of a randomised controlled trial.11 In brief, 
this study compared a preferred intensity exercise inter-
vention, in addition to treatment as usual, compared with 
a treatment as usual only control group. The sample was 
drawn from young people attending CAMHS (Child and 
Adolescent Mental Health Services) outpatient services 
in Nottingham City and Nottinghamshire County, UK. 
Participants would be attending either Tier 2 (typically 
CAMHS specialists working in primary and commu-
nity care) and Tier 3 (typically multidisciplinary teams 
in a community mental health clinic providing a more 
specialised service). To be included in the study, partic-
ipants needed to be: adolescents aged between 14 and 
17; in receipt of treatment from a health or social care 
professional for depression; and scoring 14 or above on 
the Children’s Depression Inventory-2 (CDI-2).22 The 
study comprised 86 participants, who were individually 
randomised to study groups by means of sequentially 
numbered opaque sealed envelopes. The intervention 
package consisted of a maximum of 12 sessions, deliv-
ered over a 6-week period. Sessions consisted of aerobic 
exercise in the form of circuit training, tailored to the 
exercise preferences of participants. Exercise sessions 
were scheduled for 60 min and were given in groups with 
a maximum size of 10 participants. The sessions were 
preferred intensity as participants could choose the order 
in which they undertook different exercises, the intensity 
of their exercise and when to take breaks. Participants 
were followed up for 6 months. Informed written consent 
was obtained from the legal guardians of those under the 
age of 16, alongside the young person’s assent. Informed 
written consent was obtained directly from those 16 years 
of age and over. 
costs
The perspective was that of the NHS and social services. 
All costs were for the year 2012/2013, measured in UK 
pound sterling. As the time frame of the analyses was less 
than 1 year, neither costs nor outcomes were discounted. 
The attendance of participants in the treatment group 
was recorded at each session. Sessions were run by two 
members of research staff. As this service was run from 
a CAMHS unit, data on staff and non-staff overheads 
relevant to CAMHS were taken from a published source 
of healthcare unit cost data.23 Actual costs were also 
recorded for other resource items required to provide 
the sessions, for example, the cost of room bookings.
Health and social care resource use data were collected 
using the client service receipt inventory (CSRI).24 This is 
a comprehensive inventory of resource use that has been 
widely used in economic evaluations of mental health 
interventions and can be adapted to fit individual contexts. 
Its use allows resource use patterns to be described and 
these can then be costed using appropriate unit costs. 
This instrument is designed to be adaptable and has been 
used in a wide number of different diseases, settings and 
client groups. The CSRI was completed at baseline and at 
the 6-month follow-up period by means of a face-to-face 
interview conducted by a member of the study team who 
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Table 1 Unit costs used in the analysis (UK£ 2012/2013)
Resource use item Cost Source
Inpatient stays Various NHS reference costs26
Medicines Various
British National 
Formulary25
Mental health A&E 228 NHS reference costs26
Accident and Emergency 115 NHS reference costs26
Mental health outpatient 234 NHS reference costs26
Other outpatient 187 NHS reference costs26
School nurse 14 PSSRU23
GP 37 PSSRU23
Paediatrician 187 NHS reference costs26
Physiotherapy 12 PSSRU23
Clinical psychology 68 PSSRU23
Speech therapy 15 PSSRU23
Hearing specialist 65 NHS reference costs26
Other contacts 28
Weighted average of 
reported contacts
Counselling/therapist 59 PSSRU23
Home help/care worker 19 PSSRU23
Social worker 51 PSSRU23
Overnight stay 91 PSSRU23
A&E, Accident and Emergency; GP, general practitioner; NHS, 
National Health Service; PSSRU, Personal Social Services 
Research Unit.
was blinded to study group. The time frame used was the 
last 6 months for all questions. Data were collected on the 
following: medicines; inpatient stays; use of other hospital 
services; contacts with healthcare practitioners; and social 
care. The CSRI also covered resource use relating to over-
night stays in children’s homes and foster care along-
side other services used by the respondent’s family as a 
result of the young person’s behavioural or mental health 
problems.
Resources identified were valued using the unit costs 
identified in table 1. Medicines were costed using the 
British National Formulary,25 accessed in March 2014. 
Prices obtained were deflated to 2012/2013 using the 
consumer price index. Where it was unclear what medi-
cine was prescribed, a practising general practitioner was 
consulted about typical prescribing for the reason given 
by the respondent. For inpatient stays, NHS reference 
costs were used.26 Where a stay in a mental health facility 
was recorded, a cost per day of £611 was used. Where 
the reason for admission was clear, costs were based on 
appropriate NHS reference costs. Where the reason was 
not clear, we used weighted average costs. Accident and 
Emergency (A&E) and outpatient costs were taken from 
NHS reference costs.26 For mental health-related A&E 
contacts, the cost used was that of the A&E Mental Health 
Liaison services. For other A&E visits, a weighted average 
of all non-admitted A&E contacts was used. Mental health 
outpatient contacts were estimated using a weighted 
average of outpatient and community CAMHS contacts. 
For other outpatient visits we used the cost for a paediat-
rics outpatient visit.
A range of contacts with community healthcare profes-
sionals were recorded by the CSRI. The unit costs used for 
these are also shown in table 1. Where necessary, assump-
tions on duration of contact were made. The modified 
CSRI asked for contacts with a number of different types 
of counsellor. As no further details were available, we 
assumed that all counselling services had the same cost, 
taken from a published source.23 The cost of a visit to a 
clinical psychologist was based on an assumed duration 
of contact of 30 min.23 The cost of a social worker was 
obtained from a published source.23 It was not clear what 
the duration of contacts would be so an assumption of 
20 min was used. Individuals were asked for any overnight 
stays in the last 6 months in either a children’s home, 
foster carer or any other residential placement. One indi-
vidual reported a stay in the ‘other residential placement’ 
category, and only in the baseline period. In the absence 
of any other information, we assumed this was equivalent 
to foster care and used a cost of £91 per day.23
Outcome measures
Two separate measures of outcome were used for 
the economic evaluations. First, we used the primary 
outcome measure from the clinical study, the Children’s 
Depression Inventory (CDI-2)—a 28-item self-report 
questionnaire that assesses the severity of current/recent 
depressive symptoms in young people aged 7–17 over the 
preceding 2 weeks.22 Questions on the CDI-2 have three 
possible responses: 0, corresponding to no symptoms; 
1, corresponding to probably or mild symptoms; and 2, 
corresponding to definite or marked symptoms. This 
gives a range of scores from 0 to 56 with higher scores 
representing higher depressive symptom severity. A score 
of 14 and above is considered to indicate clinical levels 
of depression.22 The CDI-2 was used in a cost-effective-
ness study to estimate cost per point change in CDI-2. 
We also carried out a cost-utility study estimating the cost 
per QALY generated by the exercise intervention. QALYs 
were estimated using the EQ-5D-5L (5-level version of 
EuroQol-5 dimension) instrument.27 This was scored 
using a published scoring algorithm.28 Both outcome 
measures were administered at baseline, postintervention 
(approximately 6 weeks after commencement of exer-
cise) and at the 6-month follow-up.
Analysis
QALYs were estimated for the follow-up period using 
‘area under the curve’. To do this, we assumed a linear 
relationship between the three data collection points 
(baseline, postintervention and follow-up). QALYs 
were estimated using the actual time of each of the 
three data collection points so length of time could 
differ between respondents. All individuals who had 
follow-up resource use data had EQ-5D scores as these 
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Table 2 Descriptive characteristics
Baseline characteristic
Full data set Complete case analysis
Control Intervention Control Intervention
Number 42 44 17 25
Percentage female (%) 81 75 88 88
Percentage white (%) 98 95 100 92
Age (years) 15.4 15.4 15.5 15.3
Baseline CDI-2 28.2 29.1 28.7 29.4
Baseline EQ-5D 0.82 0.78 0.82 0.74
Time from recruitment to follow-up (weeks) 39 37 36 36
CDI-2, Children’s Depression Inventory-2; EQ-5D, EuroQol-5 dimension.
two measures were taken together. However, there were 
four individuals for whom we had almost complete data 
except a single missing EQ-5D score in each case. The 
baseline EQ-5D score was imputed using mean value 
imputation for one individual.29 Three individuals were 
missing EQ-5D at the 6-week follow-up and values were 
imputed using multiple imputation.29 These four indi-
viduals, in addition to those individuals in who we had 
full health economics data, represented the complete 
case analysis. For individuals where the follow-up ques-
tionnaire was unavailable, costs, QALYs and differ-
ence in CDI-2 were imputed using baseline EQ-5D and 
CDI-2, time from randomisation to follow-up and base-
line total costs. Multiple imputation was carried out in 
SPSS V.23 using 50 data sets (a ‘rule of thumb’ is the 
number of data sets should equal the percentage of 
missing data).30
Regression-based methods were used to allow for 
differences in baseline characteristics.31 Differences 
between the intervention and the control group for 
both costs and outcomes were estimated using seemingly 
unrelated regression (using sureg command in STATA, 
V.11). Costs were estimated controlling for: study group, 
baseline EQ-5D-5L and baseline total cost. Estimates for 
differences in CDI-2 were controlled for: study group, 
baseline CDI-2 and time from baseline to final follow-up. 
Estimates for differences in QALY were controlled for: 
study group, baseline EQ-5D and time from baseline to 
follow-up. Estimates from the 50 imputed samples were 
combined using ‘Rubin’s Rules’.32 To estimate uncer-
tainty associated with estimates, we used bootstrap resa-
mpling with 250 replications drawn from each of the 
50 imputed data sets, giving 12 500 replications in total. 
These were used to estimate cost-effectiveness accept-
ability curves (CEAC).33
results
There were 86 individuals recruited to the study, 42 
and 44 in the control and exercise groups, respectively. 
These individuals completed CSRI by interview at base-
line. Of these, 42 (17 in control group and 25 in exer-
cise group) completed the follow-up CSRI at interview. 
Descriptive characteristics are given for all participants 
and for those in the complete case analysis (table 2). 
Baseline characteristics are similar between groups 
for both the full data set and the health economics 
complete case analysis. There were no statistically signif-
icant differences between the control and the interven-
tion group for either the full data set or the complete 
health economics data.
costs
The total time required to provide exercise sessions, 
including set-up and travel, was 2 hours. The cost, 
including overheads, for two individuals for 2 hours was 
£129; additionally, there was a charge of £23 for use of 
space in the leisure centre. This gave an estimate of £152 
for the cost of a group session. There were 44 individ-
uals randomised to the intervention group. Participants 
joined one of seven different exercise groups and each 
group had 12 scheduled sessions. This gave 82 sessions 
(two sessions were cancelled due to low numbers) and 
hence a total estimated cost for the intervention of 
£12 464. Of those in the exercise group, eight did not 
attend any sessions. There were a total of 277 attendances 
by the other individuals. This gave an average cost per 
person per session of £45.
The NHS and social care costs incurred by partici-
pants are given in table 3 for the complete case anal-
ysis. Estimated average costs at baseline were £3312 
and £3280 for control and intervention groups, respec-
tively. These differences were not statistically significant 
(independent sample t-tests). Costs were much lower in 
the follow-up period at £1301 for the control group and 
£1889 for the intervention group (this includes £351 
for the cost of the intervention). The difference in costs 
between groups was £589, with a 95% CI of −£507 to 
£1685.
Outcomes
The outcome measures used in this study are shown in 
table 4. EQ-5D-5L scores increased between baseline 
and follow-up in both groups. It can also be seen that 
the CDI-2 scores decrease (improve) in each group. Esti-
mated QALY was higher in the control group; however, 
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Table 3 Costs at baseline and in the follow-up period for control and intervention groups (£’s) 
Resource use
Baseline Follow-up
Control  
(mean (SD))
Intervention  
(mean (SD))
Control  
(mean (SD))
Intervention  
(mean (SD))
Medicines 8.5 (22.7) 28.8 (121.1) 4.3 (11) 9.5 (21)
Inpatient stays 1142 (4203) 1046 (4982) 0 (0) 44.6 (162.9)
Mental health-related Accident and Emergency 40.2 (89.6) 36.5 (85.3) 40.2 (89.6) 73 (205.2)
Other Accident and Emergency 47.4 (81.9) 27.6 (60.1) 20.3 (45.2) 13.8 (50.6)
Mental health outpatient appointments 1432 (1892) 983 (1317) 771 (1281) 983 (1525)
Other outpatient 44 (140.7) 29.9 (88.4) 110 (453.5) 89.8 (448.8)
Total costs of secondary care 2705 (5775) 2122 (5570) 941 (1310) 1204 (1632)
School nurse 11.3 (21.8) 71.7 (272) 22.5 (67.1) 0 (0)
Health visitors 0 (0) 0 (0) 0 (0) 0 (0)
Cost of dental treatment 10.3 (13.4) 13.3 (13.9) 13.9 (18.6) 8.2 (14.5)
Cost of GP visits 126.2 (88.8) 126 (175) 132.8 (107.9) 72.5 (91.6)
Cost of visits to paediatrician 44 (105.1) 37.4 (93.5) 0 (0) 15 (74.8)
Optician visits 5.9 (9.4) 8 (12.9) 1.2 (4.9) 7.2 (24.4)
Physiotherapist 2.8 (11.6) 3.8 (16.9) 0 (0) 0 (0)
Clinical psychology 0 (0) 3.6 (18) 127.1 (358.7) 0 (0)
Speech therapy 0.9 (3.6) 0 (0) 0 (0) 0 (0)
Hearing specialist 0 (0) 18.2 (69) 0 (0) 2.6 (13)
Other visits to health practitioners 37.5 (59.6) 13.9 (39.4) 0 (0) 0 (0)
Total costs of visits to health practitioners 239 (140) 296 (358) 297.5 (428.3) 105.5 (117.9)
Family counselling 31.2 (88.8) 2.4 (11.8) 0 (0) 0 (0)
Individual counselling 226 (282) 316 (423) 38.2 (142.9) 125.1 (589.6)
Other counselling 76.4 (138) 14.2 (49) 13.9 (57.2) 0 (0)
Total costs of counselling 333 (375) 333 (414) 52.1 (150.3) 125 (590)
Home help/care worker 0 (0) 6.8 (34.2) 0 (0) 15.2 (76)
Social worker 6 (24.7) 61.2 (250) 0 (0) 40.8 (204)
After school clubs 0 (0) 0 (0) 0 (0) 0 (0)
Other support services 1.1 (4.6) 0 (0) 0 (0) 0 (0)
Total costs of social care 7.1 (24.9) 68 (250) 0 (0) 56 (280)
Nights in children’s home 0 (0) 0 (0) 0 (0) 0 (0)
Nights in foster care 0 (0) 0 (0) 0 (0) 0 (0)
Nights in other residential care 0 (0) 364 (1820) 0 (0) 0 (0)
Total costs for residential care 0 (0) 364 (1820) 0 (0) 0 (0)
Service use by family related to respondents 
mental health 19.9 (64.1) 67.6 (137) 5.6 (16.2) 38.4 (139.8)
Costs of intervention – – 0 (0) 351 (144)
Total costs of follow-up 3312 (5980) 3280 (6236) 1301 (1512) 1889 (1853)
Based on a sample of 42 cases (17 in control group and 25 in intervention group).
GP, general practitioner.
this group has a higher starting EQ-5D-5L value, so mean 
unadjusted QALYs would favour this group. Therefore, 
regression methods were used to estimate both QALY 
and CDI-2 differences between the exercise and the 
control group. These results can be seen in table 5. The 
estimated difference in QALY score was −0.0027 for the 
complete case analysis and 0.0019 for the imputed anal-
ysis, both with wide CIs. Effects in terms of CDI-2 were 
slightly larger for the imputed analysis, −4.8 compared 
with −4.6 for the complete case analsyis. These indicate 
that improvements in CDI-2 score were greater in the 
exercise group compared with the control group.
Estimates of cost-effectiveness are also shown in table 5, in 
terms of incremental cost-effectiveness ratios (ICER). These 
show the additional cost of generating each additional unit 
of effect. To be consistent with the cost per QALY analysis, 
we have changed the sign of the difference in CDI-2 scores 
when calculating the ICER. This is because a decrease in 
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Table 4 Outcome measures used in the economic analyses at different study time points
Outcome measure Control mean (95% CI) Intervention mean (95% CI)
Baseline EQ-5D-5L 0.818 (0.741 to 0.895) 0.744 (0.683 to 0.804)
Postintervention EQ-5D-5L 0.841 (0.788 to 0.893) 0.823 (0.761 to 0.885)
Follow-up EQ-5D-5L 0.881 (0.836 to 0.926) 0.838 (0.768 to 0.908)
Time in study (weeks) 36.300 (31.4 to 41.3) 36.300 (32.6 to 40)
QALY 0.594 (0.507 to 0.681) 0.567 (0.494 to 0.641)
Baseline CDI-2 28.7 (25.1 to 32.4) 29.4 (25.2 to 33.6)
Follow-up CDI-2 24.6 (19.3 to 29.8) 20.4 (15.9 to 24.8)
CDI-2, Children’s Depression Inventory-2; EQ-5D-5L, 5-level version of EuroQol-5 dimension; QALY, quality-adjusted life year.
Table 5 Results of the economic analysis for both cost per point change in CDI-2 and cost per QALY
Outcome Analysis
Incremental 
cost CI
Incremental 
effect CI ICER
CDI-2 difference Complete case 334 (−606, 1274) −4.6 (−10.1, 0.87) 73*
Imputed 292 (−558, 1142) −4.8 (−10.3, 0.75) 61*
QALY difference Complete case 355 (−596, 1305) −0.0027 (−0.04, 0.03) Negative
Imputed 286 (−1063, 1634) 0.0019 (−0.063, 0.067) £152 822
*For ICERs related to change in CDI-2, the sign of the difference has been changed as a negative change in CDI-2 represents an 
improvement.
CDI-2, Children’s Depression Inventory-2; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year.
the CDI-2 represents an improvement in symptoms so is a 
positive benefit. Because of the small numbers for whom 
we have data, the results are subject to considerable uncer-
tainty and should be treated with caution. The cost per 
point improvement in the CDI-2 was £73. This decreased 
to £61 for the imputed analysis. The complete case analysis 
showed a small decrease in QALYs. This meant the ICERs 
were negative, though with considerable uncertainty. The 
imputed analysis showed very small positive QALY gains 
and an ICER of £152 822, again with considerable uncer-
tainty. CEACs for these results are shown in figures 1 and 2 
for the imputed analysis. Figure 1 indicates the probability 
that the intervention is cost-effective at different values of 
a point improvement in the CDI-2. There is a 50% prob-
ability that the intervention is cost-effective at values of a 
point change in CDI-2 of approximately £65. Due to consid-
erable uncertainty and the very small incremental effect on 
QALYs, the CEAC for the cost/QALY analysis shows much 
lower probability that the intervention is cost-effective at 
around 33%–37% at a cost per QALY of £20 000–£30 000 
(figure 2).
DIscussIOn
We found that the intervention leads to improvements in 
the CDI-2 score, costing £73 and £61 per point improve-
ment in CDI-2 for the complete case and imputed data, 
respectively. Mean costs in the follow-up period were higher 
for the intervention group, mainly due to the cost of the 
intervention. We found no evidence that the intervention 
was associated with improvements in QALYs. This study 
comprised the largest trial of its type in a clinical population 
of adolescents with depression. Additionally, as the clinical 
study had a parallel economic evaluation, we were able to 
directly assess the costs and cost-effectiveness of this inter-
vention. Data on resource use were collected in face-to-face 
interviews ensuring that that completion of individual ques-
tions was high for those who completed follow-up. Addi-
tionally, outcome measures and resource use questions 
were collected in the same interview ensuring that where 
we had resource use data we also had EQ-5D-5L data.
One weakness of the current study was that there was 
considerable loss to follow-up at the final time point. This 
was less of an issue for the study primary outcome measure, 
which was based on CDI-2 at the 6-week follow-up, but was 
more problematic for the economic evaluation. Only those 
who completed the final assessment would have completed 
the follow-up CSRI, so only 49% of participants could be 
included in the complete case analysis. We used multiple 
imputation to estimate costs and QALYs for missing cases. 
This produced a lower estimate of the cost per point change 
in CDI-2. Another potential disadvantage was that there 
were often delays between baseline data collection and 
starting the intervention. In the control group, there were 
similar delays. This meant that the total length of follow-up 
varied between participants. Mean follow-up was 36 weeks 
in both groups. As the period of recall was 26 weeks for 
the CSRI, this did not cover all costs between baseline and 
follow-up in all participants. This may have understated 
total costs in the follow-up period as average 6-month costs 
are declining over time.
The study estimated that differences between base-
line and follow-up CDI-2 were greater in the intervention 
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Figure 1 Cost-effectiveness acceptability curve for cost 
per point improvement in Children’s Depression Inventory-2 
(CDI-2).
Figure 2 Cost-effectiveness acceptability curve for cost per 
quality-adjusted life year (QALY) analysis.
group. We found no evidence to suggest that there were 
any differences in QALYs generated between groups. 
A number of different methods have been used to esti-
mate QALYs. A US study used the Health Utilities Index 
(HUI3) in an economic evaluation of a dance interven-
tion for adolescent girls with internalising problems.14 This 
intervention was considered cost-effective (US$3830 per 
QALY); however, there were differences in how the QALY 
effect was calculated, that is, this used QALY differences 
from baseline utility values whereas our study used regres-
sion-based methods to allow for differences in baseline 
characteristics. Two other US studies used depression-spe-
cific outcome measures to define an individual’s level of 
depression in order to combine this with estimates of QALY 
effects of depression level. A US study estimated QALYs by 
means of depression-free days.15 16 QALYs were estimated 
by assigning a value of 1.0 for depression-free days, and a 
value of 0.6 for days with depression. Wright et al used a 
similar approach where levels of depression were defined, 
again these were valued by utility weights for these states.17 
Both these approaches suggested differences in utility from 
the interventions. We are aware of four published studies, 
reporting on three different trials, that evaluated QALYs in 
adolescents with depression using the EQ-5D-3L.18–21 None 
of these studies found that the intervention led to improve-
ments in QALYs and did not find the intervention to be 
cost-effective.
The fact that the main clinical paper11 and the current 
economic evaluation indicated differences in CDI-2 scores 
but not in the EQ-5D-5L or QALYs may therefore be due to 
a number of factors. First, the EQ-5D may be unsuitable for 
use in adolescents with depression, that is, it may be insen-
sitive to changes that can be detected by depression-specific 
measures. We found only one published study that evaluated 
the performance of the EQ-5D in adolescents with depres-
sion.34 This study found a statistically significant correlation 
between EQ-5D and depression-specific outcome measures, 
though this relationship was stated to be weak. However, 
there is considerable evidence looking at the use of EQ-5D 
in adults with depression. A recent systematic review found 
14 studies which evaluated the performance of the EQ-5D 
in patients with depression and/or anxiety.35 The mean 
age of participants in these studies ranged from 39 to 49 
years. The authors of this systematic review concluded that 
the EQ-5D showed good construct validity and responsive-
ness for people with depression. These studies provide 
limited evidence for the use of EQ-5D in adolescents with 
depression.
Another factor may be that the current study used the 
EQ-5D-5L.27 All the currently available literature evalu-
ating the EQ-5D in depression uses the EQ-5D-3L.36 It may 
be that the 5-level version performs less well in people 
with depression. An alternative explanation for the small 
non-significant estimate of the QALY effect of the inter-
vention may simply have been that the sample size was 
insufficient to detect differences in this generic measure, 
which we would expect to be less sensitive than the depres-
sion-specific score. Alternatively, there may be differences 
in depression-related symptoms but these may not be trans-
lated into improvements in overall health-related quality of 
life. Further research using and evaluating the EQ-5D-5L in 
adolescents would be beneficial.
The current study suggests that the intervention can 
generate improvements in the CDI-2 at approximately £61 
per point change in CDI-2 (imputed analysis). This may 
represent a cost-effective intervention but it is unclear as 
to what a point change in the CDI-2 should be worth. A 
study in Korean adolescents suggested that cut of points for 
mild, moderate and severe depression on the CDI-2 could 
be 15, 20 and 25, respectively.37 A recent meta-analysis of 
utility values of health states related to depression in adults 
suggested that mild, moderate and severe depression could 
be associated with EQ-5D utility values of 0.57, 0.52 and 
0.39, respectively.38 This implies that changes in depres-
sion states can have significant implications for EQ-5D, and 
hence QALYs, and provides some evidence that the CDI-2 
differences shown in this study could be meaningful.
8 Turner D, et al. BMJ Open 2017;7:e016211. doi:10.1136/bmjopen-2017-016211
Open Access 
Additionally, it is unclear how persistent any benefits 
generated by the intervention would be. The current study 
only followed participants up for approximately 6 months. 
If benefits persisted for more than 6 months they would not 
be captured by the current design, which therefore may 
overestimate the cost per point change in CDI-2. Further-
more, the delivery of the intervention in this study was 
influenced because it was part of a clinical trial. This limited 
the numbers available for each exercise group as some 
of the potentially eligible participants would have been 
randomised into the control group. In practice, the inter-
vention could be delivered to slightly larger groups with the 
same resources and hence costs per person may be lower 
than indicated in this trial.
cOnclusIOn
Mental health practitioners are committed to using the best 
available evidence to guide their practice. It is important to 
demonstrate that any new intervention is cost-effective as 
well as being clinically effective. There is evidence that exer-
cise can be an effective intervention for adolescents with 
depression11 and the current study shows that preferred 
intensity exercise could also represent a cost-effective inter-
vention in terms of the CDI-2. However, more work would 
be needed to establish the health economic value of a point 
change in CDI-2. Incorporating exercise into the repertoire 
of interventions could add value to the care of children and 
adolescents receiving treatment and support for depression.
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